Statistics
Publications
1
Citations
10
H-Index
1
Active since
2023
Affiliations
Ken Okada is an author at Idera Pharmaceuticals (United States) specializing in toxicity management, topotecan-based therapy, and chemotherapy delivery.
Publications per year
2023–2023
1
1
Susumu Shimoyama, Ken Okada, Toshifumi Kimura et al. · Molecular Cancer Therapeutics · 2023 · 10 citations · Full text
Pharmacy, Oncology, Pharmacology +17
1–1 of 1